Contact this trialFirst, we need to learn more about you.
TCK-276 for Rheumatoid Arthritis
Recruiting0 awardsPhase 1
Mesquite, Texas
This trial tests a new oral medicine called TCK-276 in people with Rheumatoid Arthritis. It aims to see if the medicine is safe, well-tolerated, and how it moves through and affects the body.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service